Unique herbaceous annual ‘Cannabis sativa’ female plants, having numerous glandular flowers in a congested and elongated inflorescence, hollow stems a characteristic of the fiber-producing strains of ‘Cannabis sativa ssp. sativa’ but absent in strains of ‘Cannabis sativa ssp. indica.’ The plants are intoxicating, characteristic of ‘Cannabis sativa, ssp. indica’, but absent in subspecies sativa. The new strain has energizing and motivating psychoactive effects as opposed to the lethargy normally associated with ssp. indica and show hypotensive effects. Morphologically, the plants have a few branched hairs on the stem that are not characteristic of the species, but are ordinary in most other respects.

Patent
   PP27475
Priority
Mar 13 2010
Filed
Mar 13 2010
Issued
Dec 20 2016
Expiry
Apr 30 2032
Extension
779 days
Assg.orig
Entity
unknown
29
0
n/a
1. A new and distinct cultivar of ‘Cannabis’ plant, as shown and described.

The Cannabis plant named ‘Ecuadorian Sativa’ having a laboratory name of ‘CTS-A’ a variety of a cross between ‘Cannabis sativa; ssp. Sativa’ and ‘Cannabis sativa ssp. Indica (Lam.)’.

This invention relates to a novel hybrid of a cross between individuals thought to be of the two subspecies of ‘Cannabis sativa L.’, ‘Cannabis sativa; ssp. sativa’ and ‘Cannabis sativa ssp. Indica’.

Human cultivation history of Cannabis dates back 8000 years. Schultes, R E. 1970. Random thoughts and queries on the botany of Cannabis. Pages 11-38 in: CRB Joyce, and SH Curry eds., THE BOTANY AND CHEMISTRY OF CANNABIS. J. & A. Churchill. London, England. Hemp cloth recovered in Europe dates back 6000 years. (Small, E, Beckstead, H D, and Chan, A, 29(3) ECONOMIC BOTANY 29(3): 219-232 (1975). The written record of the pharmacologic properties of Cannabis goes back more than 4000 years. Ti, H. 2737 BC. NEI JING SU WEN HUANG TI (Yellow Emperor's Classic on Internal Medicine; referred to without citation in Small et al. 1975 Supra).

The taxonomy and nomenclature of the highly variable genus Cannabis (Emboden, W A, 29(3) ECONOMIC BOTANY 304-310 (1974)); (Small, E and Cronquist, A, 25(4) TAXON 405-435 (1976)); Small E and Cronquist, A 26(1) TAXON 110 (1977)); (Hillig, K W and Mahlberg, P G, 91(6) American Journal of Botany 966-975 (2004)), remains in question. This is in spite of the fact that its formal scientific name, ‘Cannabis sativa L.’, assigned by Carolus Linneaus (Linnaeus, C, 2 SPECIES PLANTARUM 1027 (1753), Salvius, Stockholm. Facsimile edition, 1957-1959. Ray Society, London, U.K.), is one of the oldest established names in botanical history and is still accepted to this day. Another species in the genus, ‘Cannabis indica Lam.’ was formally named somewhat later (de Lamarck, J B, 1(2) ENCYCLOPEDIE METHODIQUE DE BOTANIQUE, 694-5,(1785)), but is still very old in botanical history.

Three other species names were proposed in the 1800s to distinguish plants with presumably different characteristics (C. macrosperma Stokes, C. chinensis Delile, C gigantean Vilmorin), none of which are accepted today, although the epithet “indica” lives on as a subspecies of C. sativa (‘C. sativa ssp. indica Lam.’. Small and Cronquist 1976 Supra).

In the 20th century, two new names were added to the liturgy of proposed ‘Cannabis species: C. ruderalis’ Janischevsky and a hybrid, בC. intersita’ Sojak. Small, E, Jui, P Y, and Lefkovitch, L P, 1(1) SYSTEMATIC BOTANY 1(1): 67-84 (1976); Small and Cronquist 1976, Supra. Further, numerous names have been proposed for horticultural variants of ‘Cannabis’ but as of 1976, “very few of these have been validly published as formal taxa under the International Code of Botanical Nomenclature.” Small and Cronquist 1976 Supra. Moreover, other recent work continues to focus on higher-order evolutionary relationships of the genus. Cannabis has been variously ascribed as belonging to the mulberry family (Moraceae) (Engler, H G A, Ulmaceae, Moraceae and Urticaceae, pages 59-118 (1889) in: A. Engler and K. Prantl eds., DIE NATURLICHEN PFLANZENFAMILIEN 3(1). W. Engelmann, Leipzig, Germany; Judd, W S, Sanders, R W, and Donoghue, M J, 5 HARVARD PAPERS IN BOTANY 5: 1-51 (1994)); nettle family

(Urticaceae) (Berg, CC, Systematics and phylogeny of the Urticales, pages 193-220, in: P.R. Crane and S. Blackmore eds., EVOLUTION, SYSTEMATIC, AND FOSSIL HISTORY OF THE HAMAMELIDAE, VOL. 2, HIGHER HAMAMELIDAE, Clarendon Press, Oxford, U.K. (1989); Humpries, C J and Blackmore, S, A review of the classification of the Morcaceae, pages 267-277 In: Crane and Blackmore 1989 id.); and most recently in its own family with hops (Humulus), the Cannabaceae, or hemp family. Sytsma, K J, et al, 89(9) AMERICAN JOURNAL OF BOTANY 1531-1546 (2002).). While the work of Small and Cronquist 1976 Supra, seemed to effectively confine the genus to a single species with 2 subspecies (C. sativa s., C. s. indica), each with two varieties (C. s. s. var. sativa, C. s. s. var. spontanea; C. s. i. var. indica, C. s. i. var. Kafiristanica) largely on the basis of chemotaxonomy and interfertility of all forms, more recent work (Systma et al. 2002, Supra), proposes a two-species concept, resurrecting the binomial C. indica Lam. Since Sytsma et al. 2002 provides no key for discriminating between the species, the dichotomous key of Small and Cronquist 1976 Supra, which accounts for all forms in nature, whether wild or domesticated, was used to classify the characteristics of the plants described herein.

The objective of the breeding program which produced the novel plant of this invention was primarily to develop a plant having the following characteristics: (a) medicinal properties that included hypotensive activity; (b) psychoactive properties that motivated and energized, rather than creating lethargy, sleepiness, and increased food consumption.

The biologically active chemicals found in plants, phytochemicals, affect the normal structure or function of the human body and in some cases treat disease. The mechanisms for the medicinal and psychoactive properties of a cannabis plant, like any medicinal herb, are the pharmacologic effects of its phytochemicals and for a medical cannabis plant, the key phytochemicals are cannabinoids and terpenes. Tetrahydrocannabinol, THC, is the primary psychoactive and medicinal cannabinoid and is the result of the decarboxylation of tetrahydrocannabinolic acid (THC-A), its acidic precursor. THC-A, (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6h-benzochromene-2-carboxylic acid, is found in the trichomes of the plant and converted into THC, which actually exists in only minute quantities in the living plant, after harvest and drying. Cannabigerol (CBG), Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, is not considered psychoactive, is known to block the psychoactive effects of THC. and is considered medically active in a variety of conditions. Its precursor, cannabigerolic acid, CBG-A, (E)-3-(3,7-Dimethyl-2,6-octadienyl)-2,4-dihydroxy-6-pentylbenzoic acid, is being studied medically. Cannabichromene, CBC, and cannabidiol, CBD, are both non-psychoactive and end products of CBG metaolism, like THC, that are used medically Cannabichromenic acid; CBC-A, 5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentyl-chromene-6-carboxylic acid, is acidic cannabichromene.

Equadorian Sativa’ has been shown by laboratory testing by Steephill Labs to contain cannabinoid CBG-A at 2.49 mg/g, tetrahydrocannibidiol THC-A at 139.46 mg/g, THC at 2.24 mg/g and cannabinoid CBC-A at 1.75 mg/g. ‘Equadorian Sativa’ cannabinoid content is dominated by its high content of THC (2.24 mg/g) and THC-A (139.46 mg/g).

Most varieties of high potency cannabis contain large quantities of three specific terpenes as well as various assortments of others. Those three terpenes are Beta-Myrcene, Beta Caryophyllene and Linalool. For instance, the variety CT3 has a profile with a high level of Beta-Myrcene, a moderate amount of Beta Caryophyllene and a small amount of Linalool, and a moderate amount of Limonene. ‘Equadorian Sativa’ has an unusual complement of terpenes. There are small levels of Beta Myrcene, Beta Caryophyllene and Linalool, but the Limonene level is extraordinarily high at a level of 4.53, 10 to 20 times the usual range. This sets ‘Equadorian Sativa’ apart from other varieties in its odor, the effects on mood and mentation and its medical qualities.

Physically, there are indications that its use may prevent some cancers and may cause apoptosis of cancer cells in vivo. There is a good possibility that the high levels of limonene may slow down the build-up of plaque in the arteries and reduce the effect of low-density lipo-proteins on the circulatory system. Indications are that ‘Equadorian Sativa’ has many medical qualities that make it an important tool to maintain health and deal with illness.

The inventor cultivated various strains of ‘Cannabis sativa’ in an effort to create a strain best suited to control his own disorder. This plant was derived from a female said to be of a strain called colloquially, ‘Celestial Temple Sativa’ an individual grown in Ecuador that reached a height of 23 ft (7 m), and was of the typical subspecies, ‘Cannabis sativa ssp. sativa’. The male parent is said to have been of a strain known colloquially as ‘island sweet skunk’ and reportedly to belonged to the subspecies ‘Cannabis sativa ssp. indica (Lam.)’. Small and Cronquist 1976 Supra. Neither ‘Celestial Temple Sativa’ nor ‘island sweet skunk’ has been patented in the United States or elsewhere, nor are they the subject of any pending patent applications of which the inventor is aware.

The particular plant disclosed herein was discovered in the area where the inventor was intentionally cross-pollinating and cultivating plants of cross between ‘Celestial Temple Sativa’ and ‘island sweet skunk’ described above using standard Mendelian breeding procedures well known to those of ordinary skill in the art. This resulted in the F1 generation of the inventor's cross, named ‘Pleadian’. It was in the proximity of plants of the ‘Pleadian’ variety that had become hermaphroditic, in the inventor's garden in Lake Tahoe Calif. that he discovered one female plant that could only be reproduced assexually, by taking cuttings and that plant is the origin of this remarkable new strain. The female plant was discovered in a section of the inventor's hydroponic garden. The plant has been and continues to be assexually reproduced by cutting at the inventor's garden in Lake Tahoe Calif.

Comparison of the Steephill Laboratory terpenoid/cannabinoid profiles of ‘Equadorian sativa’ with other plants with the same parents, ‘island sweet skunk’ and ‘Celestial Temple Sativa’ reveals that this plant, ‘Equadorian sativa’ has a phenotypically unique profile, particular insofar as its levels of limonene. Two plants with the same parents were known by the laboratory names of CTK and CT3 and ‘Equadorian sativa’ was tested by the laboratory name of CTA. Limonene found in ‘Equadorian sativa’, were 45.35 mg/g while CTK and CT3 were only 2.24 mg/g and 1.03 mg/g respectfully. ‘Equadorian sativa’ was shown to have substantially lower levels of cannabigerolic acid (CBG-A). cannabigerol (CBG) and Beta-Myrcene. ‘Equadorian sativa’ had levels of only 2.49 mg/g of CBG-A while CTK had 6.1 mg/g CBG-A and CT3 had 8.13 mg/g of CBG-A. ‘Equadorian sativa’ had only 0.001 mg/g of CBG while CTK had 0.3 mg/g CBG and CT3 had 0.54 mg/g of CBG. ‘Equadorian sativa’ had only 1.1 mg/g Beta-Myrcene while CTK had 12.01 mg/g Beta-Myrcene and CT3 had 11.44 mg/g Beta-Myrcene.

This data is presented in tabular form in Table 1.

TABLE 1
Plant
CTA CTK CT3
Terpinoid or Cannabinoid mg/g mg/g mg/g
CBG-A 2.49 6.1 8.31
CBG 0.001 0.3 0.54
Beta Myrcene 1.1 12.02 11.44
Limonene 45.35 2.24 1.03

Asexual reproduction, colloqually known as “cloning” is a process well known to those of ordinary skill in the art of gardening and includes the following steps:

Step 1: From the female plant whose genetic profile is sought to be exactly reproduced, a 1″- 2″ cutting is taken;

Step 2: The cutting of the desired plant and is placed in a rooting solution that may be water, or a B1 vitamin that is generally the content of a rooting or cloning powder or gel;

Step 3: The cutting and rooting solution are placed into a rooting medium such as rock wool and RAPID ROOTER® a peat moss product available at hydroponics stores, gardening supply stores, and from many Internet merchants and must be water retaining so that the roots can take water up into the leaves;
Step 4: The cutting in rooting solution and rooting medium is placed under a humidity dome that may be an inverted plastic cup or is available in kits 1′-2′ long with a clear plastic dome to keep the humidity as high as possible to avoid the leaves drying before the cutting roots to insure viability;
Step 5: A a fluorescent light is placed just over the humidity dome that may be a generic work light available at hardware stores;
Step 6: One to two times a day, the humidity dome is removed for 30 seconds to insure the exchange of depleted air with fresh air to replenish the CO2.
Step 7: After maintaining this cutting in this manner, keeping the rooting medium wet at all times, for 5-14 days until root formation
Step 8: The rooted plants are maintained under flourescent high intensity lights in a soil-less medium, with standard hydroponic fertilizers, for 14 weeks;
The plant observed and identified in the photographs was cultivated in this manner at a temperature between 76 and 80 degrees Fahrenheit and was 14 weeks of age. The new plant differs from its parents and related cultivars in that it has energizing and motivating psychoactive effects as opposed to the lethargy normally associated with ssp. indica and the instant plant also shows hypotensive effects.

Observation of the all female progeny of the original plant has demonstrated that this new and distinct variety has fulfilled the objectives and that its distinctive characteristics are firmly fixed and hold true from generation to generation vegetatively propagated from the original plant.

The accompanying photographs illustrate the overall appearance of the new ‘Equadorian sativa’ plants. These photographs show the colors as true as it is reasonably possible to obtain in reproductions of this type. Colors in the photographs may differ slightly from the color values cited in the detailed botanical description which accurately describe the colors of the new plant.

Sheet 1 ‘Cannabis CTS-A’ shows the flower of the ‘Equadorian sativa’ plant in the midst of leaves from above.

The photograph at the bottom of the Sheet 2, ‘Cannabis CTS-A’ comprises a close-up view of the flowering plant of ‘Equadorian sativa’;

Sheet 3, ‘Cannabis CTS-A’ comprises a slightly oblique and very close view of the ‘Equadorian sativa’.

The following is a detailed description of the new cultivar of ‘Equadorian sativa’.

Kubby, Steven Wynn

Patent Priority Assignee Title
10105343, Apr 30 2010 KUBBY PATENT AND LICENSES, LIMITED LIABILITY COMPANY Cannabis based compositions and methods of treating hypertension
10624872, Jun 29 2017 CWB HOLDINGS, INC Apparatuses, methods, and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith
10653085, Dec 21 2018 CHARLOTTE S WEB, INC Hemp plant named ‘CW1AS1’
10777091, Jul 27 2018 CABBACIS LLC Articles and formulations for smoking products and vaporizers
10820624, Jul 27 2018 CABBACIS LLC Articles and formulations for smoking products and vaporizers
10849876, Jun 29 2017 Charlotte's Web, Inc. Apparatuses, methods and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith
10878717, Jul 27 2018 CABBACIS LLC Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
10888060, Feb 19 2020 CHARLOTTE S WEB, INC Hemp plant named ‘KIRSCHE’
10897925, Jul 27 2018 CABBACIS LLC Articles and formulations for smoking products and vaporizers
10973255, Jul 27 2018 CABBACIS LLC Articles and formulations for smoking products and vaporizers
10980773, Jun 29 2017 Charlotte's Web, Inc. Apparatuses, methods and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith
11017689, Jul 27 2018 CABBACIS LLC Very low nicotine cigarette blended with very low THC cannabis
11160781, Jun 29 2017 Charlotte's Web, Inc. Apparatuses, methods, and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith
11337954, Jun 29 2017 Charlotte's Web, Inc. Apparatuses, methods, and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith
11813833, Dec 09 2019 Owens Corning Intellectual Capital, LLC Fiberglass insulation product
ER136,
ER2404,
ER2461,
ER2667,
ER4545,
ER4805,
ER5484,
ER7189,
ER734,
ER7553,
ER7915,
ER8282,
ER9254,
ER9481,
Patent Priority Assignee Title
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Mar 13 2010KUBBY PATENT AND LICENSES, LIMITED LIABILITY COMPANY(assignment on the face of the patent)
May 13 2010KUBBY, STEVEN WYNNKUBBY PATENT AND LICENSES, LIMITED LIABILITY COMPANYASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0320050126 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule